The Compensation of Patients Injured in Clinical Trials
Barton, John M.
Macmillan, Maureen S.
Journal of Medical Ethics. 1995 Jun; 21(3): 166-169.
The problem of 'no fault' compensation for patients who suffer adverse effects as a result of their participation in clinical trials is discussed in the light of the guidelines issued by the Association of the British Pharmaceutical Industry (ABPI) and our recent experiences in reviewing protocols submitted to the local ethics of surgical research sub-committee. We have found a variety of qualifications being applied by pharmaceutical firms which are not in the spirit of the guidelines, let alone the interests of the patient, and we suggest a means whereby the patient can be assured of fair treatment in the event of 'no fault' injury.
Adverse Effects; Clinical Trials; Compensation; Drug Industry; Drugs; Ethical Review; Ethics; Ethics Committees; Guidelines; Health; Human Experimentation; Industry; Injuries; Investigators; Legal Aspects; Liability; Medical Research; Negligence; Nontherapeutic Research; Organizational Policies; Patients; Physicians; Pharmaceutical Industry; Research; Research Design; Research Ethics; Research Ethics Committees; Research Subjects; Review;
Showing items related by title, author, creator and subject.
Maintaining the Trust of Physicians and the Public in the Medical Literature: Report of a Task Force on Scientific Publishing of Clinical Trials Shane, Elizabeth; Civitelli, Roberto; Delmas, Pierre D.; Drezner, Marc; Eisman, John A.; Lindsay, Robert; Lorenzo, Joseph; Miller, Paul; Ralston, Stuart; Reid, Ian; Siris, Ethel (2007-11)
Lo, Bernard; Parham, Lindsay (2010-06)Clinical trials of stem cell transplantation raise ethical issues that are intertwined with scientific and design issues, including choice of control group and intervention, background interventions, endpoints, and selection ...